All Stories

Gilead reprimanded after PMCPA finds conference Wi-Fi sponsorship broke advertising rules

Gilead reprimanded after PMCPA finds conference Wi-Fi s...

Apr 14, 2025 0

Gilead Sciences’ sponsorship of a conference Wi-Fi network has landed it in hot ...

Theratechnologies juggles multiple suitors, including $255M offer from CDMO Future Pak

Theratechnologies juggles multiple suitors, including $...

Apr 14, 2025 0

The HIV-focused biopharma has received its latest bid from CDMO Future Pak for a...

Navigating Retail and Specialty Lite Success: How Your ...

Apr 11, 2025 0

Is your pharmacy strategy limiting success? Discover how outdated models impact ...

Amgen pads Imdelltra's case in tough-to-treat lung cancer subtype with phase 3 survival win

Amgen pads Imdelltra's case in tough-to-treat lung canc...

Apr 11, 2025 0

The drug won an accelerated approval last year in extensive-stage small cell lun...

Bristol Myers combo follows Roche, AstraZeneca immunotherapy rivals into first-line liver cancer

Bristol Myers combo follows Roche, AstraZeneca immunoth...

Apr 11, 2025 0

Bristol Myers Squibb has received the FDA’s green light to compete with Roche's ...

After Hetlioz’s rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use

After Hetlioz’s rejection in jet lag disorder, Vanda su...

Apr 11, 2025 0

After years of back-and-forth with the FDA over Hetlioz's potential use as a jet...

RFK Jr. looks to find cause of 'autism epidemic' by September through massive HHS research push

RFK Jr. looks to find cause of 'autism epidemic' by Sep...

Apr 11, 2025 0

The HHS secretary is leading the charge of a "massive testing and research drive...

Argenx stays on a roll with Vyvgart, gaining FDA nod for at-home prefilled syringe

Argenx stays on a roll with Vyvgart, gaining FDA nod fo...

Apr 11, 2025 0

Already thriving with a successful launch of infused Vyvgart and its subcutaneou...

As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay

As Pfizer backs out of hemophilia gene therapy space, C...

Apr 11, 2025 0

After Pfizer let limited patient interest get the best of its hemophilia B gene ...

Fierce Pharma Asia—Congress' US-China biotech report; NIH's database ban; GSK's ABL neuroscience deal

Fierce Pharma Asia—Congress' US-China biotech report; N...

Apr 11, 2025 0

A special congressional committee has recommended a $15 billion investment to bo...

As work on massive US plant continues, Kyowa Kirin wraps up construction of $118M biologics plant in Japan

As work on massive US plant continues, Kyowa Kirin wrap...

Apr 11, 2025 0

As work continues on a new biologics plant in the U.S., Kyowa Kirin has complete...

PhRMA calls out insurers that own PBMs, pharmacies in new ad

PhRMA calls out insurers that own PBMs, pharmacies in n...

Apr 11, 2025 0

PhRMA's latest ad highlights the double trouble that can come from pharmacy bene...

Following pledges from Lilly and J&J, Novartis unveils $23B US investment to beef up manufacturing, R&D

Following pledges from Lilly and J&J, Novartis unveils ...

Apr 10, 2025 0

As concerns around President Donald Trump's import tariffs mount, Novartis has a...

Alzheimer's Association expands PSA campaign about early dementia signs to focus on Black Americans

Alzheimer's Association expands PSA campaign about earl...

Apr 10, 2025 0

After the success of a public service advertisement campaign aimed at improving ...

Alzheimer’s Association expands PSA campaign about early dementia signs to focus on Black Americans

Alzheimer’s Association expands PSA campaign about earl...

Apr 10, 2025 0

After the success of a public service advertisement campaign aimed at improving ...

Merck granted Rob Davis a pay boost to $23.2M, inching CEO’s 2024 compensation closer to large pharma peers

Merck granted Rob Davis a pay boost to $23.2M, inching ...

Apr 10, 2025 0

Merck has handed out another hefty raise to CEO Rob Davis, boosting his compensa...

Merck granted Rob Davis a pay boost to $23.2M, inching CEO’s 2024 compensation closer to large pharma peers’

Merck granted Rob Davis a pay boost to $23.2M, inching ...

Apr 10, 2025 0

Merck has handed out another hefty raise to CEO Rob Davis, boosting his compensa...

Mucinex maker Reckitt lets go of 190 staffers in New Jersey while Organon lays off 93 amid restructuring efforts

Mucinex maker Reckitt lets go of 190 staffers in New Je...

Apr 10, 2025 0

Reckitt Beckiser and Organon are laying off employees in New Jersey as both comp...

Few psych drugs from past decade are on HCPs' radars: survey

Few psych drugs from past decade are on HCPs' radars: s...

Apr 10, 2025 0

Ask a healthcare professional to name a psychiatric medicine and chances are the...

Sun Pharma snags appeals win over Incyte, clearing way for US launch of alopecia med Leqselvi

Sun Pharma snags appeals win over Incyte, clearing way ...

Apr 10, 2025 0

After Sun Pharma appealed an injunction handed down in New Jersey federal court ...

Few psych drugs from past decade are on HCPs’ radars: survey

Few psych drugs from past decade are on HCPs’ radars: s...

Apr 10, 2025 0

Ask a healthcare professional to name a psychiatric medicine and chances are the...

Regulatory tracker: China approves its first gene therapy

Regulatory tracker: China approves its first gene therapy

Apr 10, 2025 0

In this tracker, Fierce Pharma is recording the regulatory progress of in-market...

Jazz Pharma forks over $145M to shake off antitrust claims tied to narcolepsy drug Xyrem

Jazz Pharma forks over $145M to shake off antitrust cla...

Apr 10, 2025 0

The company settled with several purchaser plaintiffs in an antitrust case that ...

Large drugmakers spent millions protecting their CEOs last year amid 'heightened risk environment'

Large drugmakers spent millions protecting their CEOs l...

Apr 9, 2025 0

With fears increased in the healthcare industry that top executives could be tar...

1
2
3
4

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.